In this study, minor heterogeneities were observed with respect to OS, DFS, tumor size, clinical stage, and histological grade; however, there were substantial heterogeneities with respect to ER status, HER2 status, lymph node infiltration, and different subtypes of breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.